The estimated Net Worth of Hal Landy is at least $1.43 Million dollars as of 19 June 2007. Hal Landy owns over 40,000 units of Repligen stock worth over $1,434,000 and over the last 21 years Hal sold RGEN stock worth over $0.
Hal has made over 2 trades of the Repligen stock since 2004, according to the Form 4 filled with the SEC. Most recently Hal exercised 40,000 units of RGEN stock worth $110,000 on 19 June 2007.
The largest trade Hal's ever made was exercising 40,000 units of Repligen stock on 19 June 2007 worth over $110,000. On average, Hal trades about 13,750 units every 271 days since 2004. As of 19 June 2007 Hal still owns at least 10,000 units of Repligen stock.
You can see the complete history of Hal Landy stock trades at the bottom of the page.
Hal's mailing address filed with the SEC is C/O REPLIGEN CORPORATION, 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453.
Over the last 22 years, insiders at Repligen have traded over $118,224,292 worth of Repligen stock and bought 160,440 units worth $1,459,521 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Glenn P Muir und Walter C Herlihy. On average, Repligen executives and independent directors trade stock every 33 days with the average trade being worth of $3,015,702. The most recent stock trade was executed by Ralf Kuriyel on 2 August 2024, trading 7,148 units of RGEN stock currently worth $1,139,034.
repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. we are a leading manufacturer of protein a, a critical reagent used to manufacture monoclonal antibody-based therapeutics. we also supply several growth factor products used to increase cell culture productivity in biomanufacturing. in the burgeoning area of disposable biomanufacturing technologies, we have developed and market a series of opus™ (open platform user specified) single-use chromatography columns used in the biologics purification process. repligen’s corporate headquarters are located in waltham, ma, usa; we have an additional manufacturing facility in lund, sweden.
Repligen executives and other stock owners filed with the SEC include: